Literature DB >> 10791515

Which surfactant for treatment of respiratory-distress syndrome.

A H Jobe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10791515     DOI： 10.1016/S0140-6736(00)02130-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Pulmonary surfactant: a front line of lung host defense.

Authors:  Jo Rae Wright
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice.

Authors:  Stephan W Glasser; Albert P Senft; Jeffrey A Whitsett; Melissa D Maxfield; Gary F Ross; Theresa R Richardson; Daniel R Prows; Yan Xu; Thomas R Korfhagen
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

3.  Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress.

Authors:  Mehmet Yalaz; Sema Tanriverdi; Özgün Uygur; Özge Altun Köroğlu; Elif Azarsiz; Guzide Aksu; Nilgün Kültürsay
Journal:  Front Pediatr       Date:  2022-03-18       Impact factor: 3.418
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.